Monday, February 1, 2021

No One Is Immune

 

By Matthew Klein |  Friday, January 29

Immune Response. At the end of the day, nothing matters more to the markets than the state of the pandemic. So discouraging news about the effectiveness of new vaccines—especially against the more virulent mutations that have emerged in places such as England and South Africa—is going to be bad for share prices.

That helps explain the massive drops in the major U.S. indices today, with the S&P 500 down 1.9% and the Russell 2000 small-cap index down 1.6%. It’s also consistent with the fact that the biggest losers of the day include pandemic-sensitive stocks such as Norwegian Cruise Lines, United Airlines, Royal Caribbean Cruises, Kimco Realty, Carnival, and Delta Air Lines. All of those stocks were down at least 5% on Friday.

Given the global nature of the pandemic, the bad news wasn’t confined to the United States. Europe’s STOXX 600 index and Japan’s Nikkei 225 were also down 1.9%. The Hang Seng was down about 1%, Canada’s TSX and the FTSE 100 were down 1.8%, while Korea’s KOSPI Composite was down 3%.

It’s worth noting that that Johnson & Johnson’s vaccine was shown to be 85% effective at preventing severe disease and completely eliminated hospitalization and death, 28 days post-vaccination. 

The impact of virus news on overall asset prices has been exacerbated by peculiarities of market structure. When heavily-shorted small-cap stocks get squeezed “to the moon,” as the new saying goes, it forces the shorts to liquidate their long positions to raise cash. GameStop and AMC Entertainment may have gained 68% and 54% today, respectively, but those gains came in part at the expense of the rest of the market. Only 59 components of the S&P 500 were up today, while all 11 sectors were down. Utility stocks fared the best on a relative basis, with the sector down 0.5%.

More generally, if short-selling is no longer a viable way to make money, it makes it harder for investors to hedge their long positions. That means anyone who had been using shorts to help target a given risk profile now has to sell shares in companies they think should do well. That’s bad for the market longer term, even if it’s beneficial for fraudsters and other targets of short-sellers.

There was some clearly good news today: the Bureau of Economic Analysis reported that Americans earned more total wage and salary income in December than in any month before the pandemic on a seasonally-adjusted basis. While there are still roughly 10 million fewer Americans with jobs than there were in February, higher pay for everyone who is still employed has offset the aggregate impact on labor income. Assuming vaccinations do their job, those higher wages should help power the consumer recovery later this year.

Watch our TV show on Fox Business Fridays at 10 p.m. or 11:30 p.m. ET; Saturdays at 10 a.m. or 11:30 a.m.; or Sundays at 7 a.m., 10 a.m., or 11:30 a.m. This week, see interviews with Brian Moynihan, Chairman and CEO of Bank of America, and Todd Ahlsten, chief investment officer of Parnassus Investments. Plus, get more insights on the mania surrounding GameStop.

 

 


No comments:

Post a Comment